News
The “Top 10” list of best-selling gene therapies published by Genetic Engineering & Biotechnology News (GEN) in their May 2025 issue features three products based upon license agreements for technologies originating from the NIH Intramural Research Program. Featured and ranked on the GEN list are
Have you missed networking and learning from other technology transfer professionals in person? The Federal Laboratory Consortium (FLC) is here to help – they are hosting their first in-person National Meeting in three years! The 2023 FLC National Meeting will be held from March 28-30 th in
The NIH Technology Transfer Program has won the Licensing Executive Society’s Deals of Distinction award for 2022. The Deals of Distinction Award is given to an outstanding licensing deal from the past year. Steve Ferguson, Special Advisor at the NIH Office of Technology Transfer, recently attended
Cell Lines for the Study of Neurodegenerative Disorders and their Treatments Available for Licensing
Gaucher disease is a rare and heterogenous disorder caused by inherited Glucocerebrosidase (GBA1) genetic mutations. The National Human Genome Research Institute (NHGRI) has six cell lines available for licensing for the study of GBA1 mutations. These cell lines can be used to study the defects in